Oncternal Therapeutics, Inc.

NasdaqCM:ONCT Stock Report

Market Cap: US$1.6m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Oncternal Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:ONCT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
08 Apr 24BuyUS$27,655Robert WillsIndividual3,086US$8.96
28 Mar 24BuyUS$58,602Robert WillsIndividual6,914US$8.48
23 Feb 24BuyUS$6,455David HaleIndividual714US$9.04
23 Feb 24BuyUS$2,405Hale BioPharma Ventures LLCCompany266US$9.04
23 Feb 24SellUS$8,859Robert WillsIndividual980US$9.04

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ONCT?
Owner TypeNumber of SharesOwnership Percentage
Private Companies30,5901.03%
Individual Insiders71,7062.42%
Public Companies150,9885.1%
Institutions394,49113.3%
General Public2,311,87078.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 21.66% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.1%
Shanghai Pharmaceuticals Holding Co., Ltd
150,988US$79.5k0%no data
4.73%
The Vanguard Group, Inc.
139,884US$73.7k-2.21%no data
2.07%
Millennium Management LLC
61,205US$32.2k-40.5%no data
1.34%
BlackRock, Inc.
39,706US$20.9k1.09%no data
1.11%
James Breitmeyer
32,783US$17.3k0%no data
1%
Hale BioPharma Ventures LLC
29,673US$15.6k0%no data
0.89%
Dimensional Fund Advisors LP
26,298US$13.8k0%no data
0.87%
Geode Capital Management, LLC
25,879US$13.6k0%no data
0.84%
Pasadena Private Wealth, LLC
25,000US$13.2k0%no data
0.6%
Renaissance Technologies LLC
17,905US$9.4k4.07%no data
0.48%
Morgan Stanley, Investment Banking and Brokerage Investments
14,152US$7.5k-6.07%no data
0.45%
Quantum Private Wealth, LLC
13,187US$6.9k-51%no data
0.41%
Virtu Financial LLC, Asset Management Arm
12,276US$6.5k0%no data
0.34%
Robert Wills
10,000US$5.3k0%no data
0.25%
Tareno International Asset Managers
7,399US$3.9k0%no data
0.25%
Richard Vincent
7,363US$3.9k0%no data
0.22%
Salim Yazji
6,431US$3.4k0%no data
0.14%
Chase Leavitt
4,238US$2.2k0%no data
0.12%
Michael Carter
3,597US$1.9k0%no data
0.11%
Welzia Management SGIIC SA
3,164US$1.7k0%no data
0.095%
Tower Research Capital Europe Limited
2,822US$1.5k354%no data
0.074%
Rajesh Krishnan
2,201US$1.2k0%no data
0.062%
Gunnar Kaufmann
1,833US$965.20%no data
0.062%
Acadian Asset Management LLC
1,829US$963.20%no data
0.044%
William LaRue
1,308US$688.70%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/04 18:05
End of Day Share Price 2024/12/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Oncternal Therapeutics, Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kaveri PohlmanBTIG
Li Wang WatsekCantor Fitzgerald & Co.
Carl ByrnesNorthland Capital Markets